代谢健康的肥胖是否是由炎症,性别差异和脂肪分布所塑造的?
Davide Ramoni1, Luca Liberale1,2, Federico Carbone1,2
1Department of Internal Medicine, University of Genoa, Genoa 16132, Italy.
World journal of cardiology
|September 15, 2025
概括
代谢健康的肥胖 (MHO) 仍然会增加心血管风险,尤其是炎症,性别和脂肪分布因素. 考虑到这些因素的个性化护理对于更好的预防和结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 代谢健康 代谢健康
- 炎症生物学 炎症生物学
背景情况:
- 全球肥胖流行病带来了重大的心血管 (CV) 健康挑战.
- 不同的肥胖现象,特别是代谢健康的肥胖 (MHO) 与不健康的个人资料,赋予不同的心血管风险.
- 即使是MHO也与不良CV事件的增加有关,特别是与社会经济劣势有关.
研究的目的:
- 突出慢性低度炎症 ("元炎症") 在与MHO相关的心血管风险中的作用.
- 强调性别和脂肪分布 (表心,内脏脂肪) 对心血管脆弱性的影响.
- 倡导心脏代谢护理的范式转变,朝着更精细的风险评估.
主要方法:
- 审查最近的大规模研究和关于肥胖表型和心血管健康的新兴证据.
- 分析慢性炎症,脂肪分布,衰老和荷尔蒙变化对心血管风险的贡献.
- 探索影响MHO不稳定性和心血管脆弱性的性别特定因素.
主要成果:
- MHO与心血管事件风险增加有关,受炎症,性别和脂肪分布的影响.
- 副心脏和内脏脂肪增加促发炎状态,与心力衰竭和心房有关.
- 老龄化和荷尔蒙变化,特别是在女性中,可以破坏MHO的稳定,增加心血管脆弱性.
结论:
- 需要在心脏代谢护理方面进行范式转变,整合炎症生物标志物,脂肪分布和超越人类学的性别特异因素.
- 识别表型差异允许更准确的CV风险分层.
- 了解肥胖症中心血管风险背后的"为什么"对于基于精度的治疗和改善不同人群的结果至关重要.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225


